ALEJANDRO
LOPEZ SOTO
Profesor Ayudante Doctor
Hospital Universitario Central de Asturias
Oviedo, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Central de Asturias (31)
2023
-
BTLA dysregulation correlates with poor outcome and diminished T cell-mediated antitumor responses in chronic lymphocytic leukemia
Cancer Immunology, Immunotherapy, Vol. 72, Núm. 7, pp. 2529-2539
2021
2020
-
Daratumumab is a safe and effective rescue therapy for multiple myeloma patients who relapse after allo-HSCT
Bone Marrow Transplantation
-
Mechanisms of apoptosis resistance to NK cell-mediated cytotoxicity in cancer
International Journal of Molecular Sciences, Vol. 21, Núm. 10
2019
-
NK cell-based immunotherapy in cancer metastasis
Cancers, Vol. 11, Núm. 1
-
The Mithralog EC-7072 Induces Chronic Lymphocytic Leukemia Cell Death by Targeting Tonic B-Cell Receptor Signaling
Frontiers in Immunology, Vol. 10
2018
-
Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia
Frontiers in immunology, Vol. 9, pp. 2917
2017
-
Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia
OncoImmunology, Vol. 6, Núm. 10
-
Immune and inflammatory responses to DNA damage in cancer and aging
Mechanisms of Ageing and Development, Vol. 165, pp. 10-16
-
Immunosurveillance of Malignant Cells with Complex Karyotypes
Trends in Cell Biology
-
Involvement of autophagy in NK cell development and function
Autophagy
-
NKG2D Signaling: The Immune Subversive Side of HDAC3
Trends in Immunology
2016
-
Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors
OncoImmunology, Vol. 5, Núm. 2
-
The Molecular Basis of the Immune Response to Stressed Cells and Tissues
The Innate Immune Response to Non-infectious Stressors: Human and Animal Models (Elsevier Inc.), pp. 53-79
2015
2014
-
Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia.Correlation with progressive disease
PLoS ONE, Vol. 9, Núm. 10
-
Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells
BioMed Research International, Vol. 2014
-
Molecular bases for the regulation of NKG2D ligands in cancer
Frontiers in Immunology
2013
-
Epithelial-mesenchymal transition induces an antitumor immune response mediated by NKG2D receptor
Journal of Immunology, Vol. 190, Núm. 8, pp. 4408-4419